Yifan Pharmaceutical Co., Ltd. (002019.SZ)
CNY 11.38
(0.53%)
CNY 11.38
(0.53%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 11.49 Billion CNY | -8.32% |
| 2022 | 12.54 Billion CNY | 3.11% |
| 2021 | 12.16 Billion CNY | 4.54% |
| 2020 | 11.63 Billion CNY | 5.16% |
| 2019 | 11.06 Billion CNY | 13.21% |
| 2018 | 9.77 Billion CNY | 11.49% |
| 2017 | 8.76 Billion CNY | 25.55% |
| 2016 | 6.98 Billion CNY | 53.59% |
| 2015 | 4.54 Billion CNY | 36.35% |
| 2014 | 3.33 Billion CNY | 214.3% |
| 2013 | 1.06 Billion CNY | -0.05% |
| 2012 | 1.06 Billion CNY | -8.98% |
| 2011 | 1.16 Billion CNY | -2.93% |
| 2010 | 1.2 Billion CNY | 5.35% |
| 2009 | 1.14 Billion CNY | 33.19% |
| 2008 | 856.26 Million CNY | -3.18% |
| 2007 | 884.41 Million CNY | 51.87% |
| 2006 | 582.35 Million CNY | 12.65% |
| 2005 | 516.94 Million CNY | 44.12% |
| 2004 | 358.7 Million CNY | 80.22% |
| 2003 | 199.03 Million CNY | 50.83% |
| 2002 | 131.96 Million CNY | 51.04% |
| 2001 | 87.36 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 12.13 Billion CNY | 3.02% |
| 2024 Q1 | 11.78 Billion CNY | 2.45% |
| 2024 Q3 | 12.36 Billion CNY | 1.92% |
| 2023 FY | 11.49 Billion CNY | -8.32% |
| 2023 Q2 | 12.58 Billion CNY | -0.07% |
| 2023 Q3 | 12.34 Billion CNY | -1.85% |
| 2023 Q4 | 11.49 Billion CNY | -6.86% |
| 2023 Q1 | 12.58 Billion CNY | 0.36% |
| 2022 Q1 | 12.49 Billion CNY | 2.75% |
| 2022 Q3 | 12.69 Billion CNY | 1.75% |
| 2022 FY | 12.54 Billion CNY | 3.11% |
| 2022 Q2 | 12.47 Billion CNY | -0.19% |
| 2022 Q4 | 12.54 Billion CNY | -1.18% |
| 2021 Q1 | 12.11 Billion CNY | 4.09% |
| 2021 Q4 | 12.16 Billion CNY | 1.57% |
| 2021 FY | 12.16 Billion CNY | 4.54% |
| 2021 Q2 | 12.02 Billion CNY | -0.75% |
| 2021 Q3 | 11.97 Billion CNY | -0.37% |
| 2020 Q3 | 11.99 Billion CNY | 1.55% |
| 2020 Q1 | 11.58 Billion CNY | 4.68% |
| 2020 FY | 11.63 Billion CNY | 5.16% |
| 2020 Q2 | 11.81 Billion CNY | 1.97% |
| 2020 Q4 | 11.63 Billion CNY | -2.98% |
| 2019 Q4 | 11.06 Billion CNY | 6.85% |
| 2019 Q3 | 10.35 Billion CNY | 2.21% |
| 2019 FY | 11.06 Billion CNY | 13.21% |
| 2019 Q1 | 9.71 Billion CNY | -0.65% |
| 2019 Q2 | 10.13 Billion CNY | 4.33% |
| 2018 Q4 | 9.77 Billion CNY | 5.89% |
| 2018 Q1 | 9.08 Billion CNY | 3.63% |
| 2018 FY | 9.77 Billion CNY | 11.49% |
| 2018 Q2 | 8.98 Billion CNY | -1.1% |
| 2018 Q3 | 9.23 Billion CNY | 2.72% |
| 2017 FY | 8.76 Billion CNY | 25.55% |
| 2017 Q3 | 8.75 Billion CNY | 25.73% |
| 2017 Q2 | 6.95 Billion CNY | 2.22% |
| 2017 Q1 | 6.8 Billion CNY | -2.51% |
| 2017 Q4 | 8.76 Billion CNY | 0.2% |
| 2016 FY | 6.98 Billion CNY | 53.59% |
| 2016 Q1 | 4.8 Billion CNY | 5.63% |
| 2016 Q2 | 6.57 Billion CNY | 36.88% |
| 2016 Q4 | 6.98 Billion CNY | 1.63% |
| 2016 Q3 | 6.87 Billion CNY | 4.52% |
| 2015 Q4 | 4.54 Billion CNY | 13.11% |
| 2015 Q3 | 4.01 Billion CNY | 7.11% |
| 2015 Q2 | 3.75 Billion CNY | 9.83% |
| 2015 Q1 | 3.41 Billion CNY | 2.46% |
| 2015 FY | 4.54 Billion CNY | 36.35% |
| 2014 Q4 | 3.33 Billion CNY | 4.16% |
| 2014 Q3 | 3.2 Billion CNY | 177.5% |
| 2014 Q1 | 1.09 Billion CNY | 3.1% |
| 2014 Q2 | 1.15 Billion CNY | 5.46% |
| 2014 FY | 3.33 Billion CNY | 214.3% |
| 2013 FY | 1.06 Billion CNY | -0.05% |
| 2013 Q4 | 1.06 Billion CNY | 0.93% |
| 2013 Q3 | 1.05 Billion CNY | 0.53% |
| 2013 Q2 | 1.04 Billion CNY | -2.15% |
| 2013 Q1 | 1.06 Billion CNY | 0.66% |
| 2012 FY | 1.06 Billion CNY | -8.98% |
| 2012 Q2 | 1.05 Billion CNY | -11.52% |
| 2012 Q4 | 1.06 Billion CNY | 5.58% |
| 2012 Q3 | 1 Billion CNY | -5.13% |
| 2012 Q1 | 1.19 Billion CNY | 2.71% |
| 2011 Q2 | 1.27 Billion CNY | 1.54% |
| 2011 Q4 | 1.16 Billion CNY | -8.8% |
| 2011 Q3 | 1.27 Billion CNY | 0.66% |
| 2011 Q1 | 1.25 Billion CNY | 4.13% |
| 2011 FY | 1.16 Billion CNY | -2.93% |
| 2010 Q2 | 1.31 Billion CNY | 9.01% |
| 2010 Q4 | 1.2 Billion CNY | -9.68% |
| 2010 Q3 | 1.33 Billion CNY | 1.02% |
| 2010 FY | 1.2 Billion CNY | 5.35% |
| 2010 Q1 | 1.2 Billion CNY | 5.91% |
| 2009 Q1 | 884.25 Million CNY | 3.27% |
| 2009 Q4 | 1.14 Billion CNY | -9.15% |
| 2009 FY | 1.14 Billion CNY | 33.19% |
| 2009 Q2 | 880.88 Million CNY | -0.38% |
| 2009 Q3 | 1.25 Billion CNY | 42.5% |
| 2008 FY | 856.26 Million CNY | -3.18% |
| 2008 Q3 | 891.44 Million CNY | -3.41% |
| 2008 Q2 | 922.87 Million CNY | 2.69% |
| 2008 Q1 | 898.73 Million CNY | 1.62% |
| 2008 Q4 | 856.26 Million CNY | -3.95% |
| 2007 Q2 | 667.89 Million CNY | 13.9% |
| 2007 Q1 | 586.37 Million CNY | 0.69% |
| 2007 Q3 | 759.92 Million CNY | 13.78% |
| 2007 Q4 | 884.41 Million CNY | 16.38% |
| 2007 FY | 884.41 Million CNY | 51.87% |
| 2006 Q1 | 524.31 Million CNY | 1.43% |
| 2006 Q3 | 548.5 Million CNY | 3.6% |
| 2006 FY | 582.35 Million CNY | 12.65% |
| 2006 Q4 | 582.35 Million CNY | 6.17% |
| 2006 Q2 | 529.45 Million CNY | 0.98% |
| 2005 FY | 516.94 Million CNY | 44.12% |
| 2005 Q1 | 416.9 Million CNY | 16.23% |
| 2005 Q2 | 472.98 Million CNY | 13.45% |
| 2005 Q3 | 507.81 Million CNY | 7.36% |
| 2005 Q4 | 516.94 Million CNY | 1.8% |
| 2004 FY | 358.7 Million CNY | 80.22% |
| 2004 Q3 | 358.27 Million CNY | 54.69% |
| 2004 Q2 | 231.6 Million CNY | 0.0% |
| 2004 Q4 | 358.7 Million CNY | 0.12% |
| 2003 FY | 199.03 Million CNY | 50.83% |
| 2003 Q4 | 199.03 Million CNY | 0.0% |
| 2002 FY | 131.96 Million CNY | 51.04% |
| 2001 FY | 87.36 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 13.9 Billion CNY | 17.322% |
| Zhejiang Zhenyuan Share Co., Ltd. | 2.98 Billion CNY | -285.35% |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. | 1.06 Billion CNY | -984.512% |
| Hubei Guangji Pharmaceutical Co., Ltd. | 3.02 Billion CNY | -279.585% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | 847.56 Million CNY | -1256.782% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 36.52 Billion CNY | 68.516% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | 2.89 Billion CNY | -297.788% |
| Boai NKY Medical Holdings Ltd. | 4.01 Billion CNY | -186.081% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | 2.56 Billion CNY | -348.823% |